Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kenneth Lee Insider Profile
4 Followers
Kenneth Lee, Director at Aralez Pharmaceuticals, holds 68.86K shares in BioCryst (Ticker: BCRX), holds 64.54K shares in Eyenovia (Ticker: EYEN), holds 81.95K shares in Aralez Pharmaceuticals (Ticker: ARLZQ).
Profitable Transactions
2 out of 6 Profitable Transactions
Average Return
-1.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
The most profitable trade made by Kenneth Lee
Kenneth Lee's Trading History
Aralez Pharmaceuticals
May 12, 2017
―
Uninformative Buy
―
$163.90
Eyenovia
Jun 21, 2022
Director
Uninformative Buy
―
$55.83K
BioCryst
Jun 15, 2023
Director
Uninformative Buy
―
$351.20K
Maxygen
Sep 24, 2009
―
Uninformative Buy
―
―
List of latest transactions for each holding click on a transaction to see Kenneth Lee's performance on stock
You May Also Like
Kenneth Lee insider profile FAQ
What is the percentage of profitable transactions made by Kenneth Lee?
The percentage of profitable transactions made by Kenneth Lee is 33%.
What is the average return per transaction made by Kenneth Lee?
The average return per transaction made by Kenneth Lee is -1.90%.
What stocks does Kenneth Lee hold?
Kenneth Lee holds: ARLZQ, EYEN, BCRX, MAXY stocks.
What was Kenneth Lee’s latest transaction?
Kenneth Lee latest transaction was an Uninformative Buy of ―.
What was Kenneth Lee's most profitable transaction?
Kenneth Lee’s most profitable transaction was an Informative Buy of BCRX stock on November 18, 2019. The return on the trade was 151.70%.
What is Kenneth Lee's role in Aralez Pharmaceuticals?
Kenneth Lee's role in Aralez Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.